Whole Exome Sequencing in South Africa: Stakeholder Views on Return of Individual Research Results and Incidental Findings

The use of whole exome sequencing (WES) in medical research is increasing in South Africa (SA), raising important questions about whether and which individual genetic research results, particularly incidental findings, should be returned to patients. Whilst some commentaries and opinions related to the topic have been published in SA, there is no qualitative data on the views of professional stakeholders on this topic. Seventeen participants including clinicians, genomics researchers, and genetic counsellors (GCs) were recruited from the Western Cape in SA. Semi-structured interviews were conducted, and the transcripts analysed using the framework approach for data analysis. Current roadblocks for the clinical adoption of WES in SA include a lack of standardised guidelines; complexities relating to variant interpretation due to lack of functional studies and underrepresentation of people of African ancestry in the reference genome, population and variant databases; lack of resources and skilled personnel for variant confirmation and follow-up. Suggestions to overcome these barriers include obtaining funding and buy-in from the private and public sectors and medical insurance companies; the generation of a locally relevant reference genome; training of health professionals in the field of genomics and bioinformatics; and multidisciplinary collaboration. Participants emphasised the importance of upscaling the accessibility to and training of GCs, as well as upskilling of clinicians and genetic nurses for return of genetic data in collaboration with GCs and medical geneticists. Future research could focus on exploring the development of stakeholder partnerships for increased access to trained specialists as well as community engagement and education, alongside the development of guidelines for result disclosure.

[1]  Jared O'Connell,et al.  A population-specific reference panel for improved genotype imputation in African Americans , 2021, Communications Biology.

[2]  Shunmin He,et al.  NyuWa Genome resource: A deep whole-genome sequencing-based variation profile and reference panel for the Chinese population. , 2021, Cell reports.

[3]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.

[4]  Andreas Henschel,et al.  A Population-Specific Major Allele Reference Genome From The United Arab Emirates Population , 2021, Frontiers in Genetics.

[5]  William T. Harvey,et al.  Haplotype-resolved diverse human genomes and integrated analysis of structural variation , 2021, Science.

[6]  G. Paré,et al.  Whole exome sequencing reveals a biallelic frameshift mutation in GRXCR2 in hearing impairment in Cameroon , 2021, Molecular genetics & genomic medicine.

[7]  A. Wonkam Sequence three million genomes across Africa , 2021, Nature.

[8]  I. Munabi,et al.  Researchers’ perspectives on return of individual genetics results to research participants: a qualitative study , 2021, Global bioethics = Problemi di bioetica.

[9]  Heng Li,et al.  The design and construction of reference pangenome graphs with minigraph , 2020, Genome biology.

[10]  R. Wilkinson,et al.  Human whole genome sequencing in South Africa , 2020, bioRxiv.

[11]  M. Kotze,et al.  Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing , 2020, Frontiers in Genetics.

[12]  S. Soddu,et al.  Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers , 2020, Journal of Experimental & Clinical Cancer Research.

[13]  Shuyang Zhang,et al.  A call for global action for rare diseases in Africa , 2019, Nature Genetics.

[14]  R. Dorrington,et al.  Burden of disease in South Africa: Protracted transitions driven by social pathologies. , 2019, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[15]  K. Kinoshita,et al.  Construction and integration of three de novo Japanese human genome assemblies toward a population-specific reference , 2019, bioRxiv.

[16]  J. de Vries,et al.  Returning incidental findings in African genomics research , 2019, Nature Genetics.

[17]  Hongyu Zhao,et al.  HUPAN: a pan-genome analysis pipeline for human genomes , 2019, Genome Biology.

[18]  G. Mazandu,et al.  Dissecting in silico Mutation Prediction of Variants in African Genomes: Challenges and Perspectives , 2019, Front. Genet..

[19]  K. Ormond,et al.  The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results. , 2019, American journal of human genetics.

[20]  A. Krause New genetic testing technologies: Advantages and limitations , 2019, South African Medical Journal.

[21]  Scott M. Williams,et al.  The Missing Diversity in Human Genetic Studies , 2019, Cell.

[22]  A. Dobin,et al.  Is it time to change the reference genome? , 2019, bioRxiv.

[23]  Alicia R. Martin,et al.  The critical needs and challenges for genetic architecture studies in Africa. , 2018, Current opinion in genetics & development.

[24]  D. MacArthur,et al.  Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy , 2017, Orphanet Journal of Rare Diseases.

[25]  Lars Bolund,et al.  Sequencing and de novo assembly of 150 genomes from Denmark as a population reference , 2017, Nature.

[26]  C. Klaver,et al.  Whole-Exome Sequencing Identifies Biallelic IDH3A Variants as a Cause of Retinitis Pigmentosa Accompanied by Pseudocoloboma. , 2017, Ophthalmology.

[27]  Monique M. Ryan,et al.  Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy , 2017, Annals of clinical and translational neurology.

[28]  M. Kotze,et al.  Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway , 2017, International journal of molecular sciences.

[29]  Clara Gaff,et al.  Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement , 2017, Genetics in Medicine.

[30]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[31]  Rolf Schröder,et al.  Clinical exome sequencing: results from 2819 samples reflecting 1000 families , 2016, European Journal of Human Genetics.

[32]  Jefferey Chen,et al.  Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing. , 2016, The Journal of molecular diagnostics : JMD.

[33]  A. Swaroop,et al.  Molecular Diagnosis of Inherited Retinal Diseases in Indigenous African Populations by Whole-Exome Sequencing , 2016, Investigative ophthalmology & visual science.

[34]  Zachary A. Szpiech,et al.  Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry , 2016, Nature Communications.

[35]  Michael Parker,et al.  Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies , 2016, Genetics in Medicine.

[36]  Y. Joly,et al.  Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views , 2016, BMC Medical Genomics.

[37]  Mahmoud Zirie,et al.  The Qatar genome: a population-specific tool for precision medicine in the Middle East , 2016, Human Genome Variation.

[38]  Michelle D. Brazas,et al.  Continuing Education Workshops in Bioinformatics Positively Impact Research and Careers , 2016, PLoS Comput. Biol..

[39]  J. Mullikin,et al.  Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants. , 2016, Clinical chemistry.

[40]  Anke M Hövels,et al.  Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability , 2016, Genetics in Medicine.

[41]  D. Stein,et al.  Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents , 2015, Journal of Medical Ethics.

[42]  Si Quang Le,et al.  Building Population-Specific Reference Genomes: A Case Study of Vietnamese Reference Genome , 2015, 2015 Seventh International Conference on Knowledge and Systems Engineering (KSE).

[43]  L. Ehler,et al.  Considering Actionability at the Participant's Research Setting Level for Anticipatable Incidental Findings from Clinical Research , 2015, Journal of Law, Medicine & Ethics.

[44]  F. Zou,et al.  Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center’s Experience , 2015, Front. Pediatr..

[45]  Jonathan S Berg,et al.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. , 2015, American journal of human genetics.

[46]  S. Sisodiya Genetic screening and diagnosis in epilepsy? , 2015, Current opinion in neurology.

[47]  Avni Santani,et al.  Actionable exomic incidental findings in 6503 participants: challenges of variant classification , 2015, Genome research.

[48]  Jennifer B. McCormick,et al.  Patients' views on incidental findings from clinical exome sequencing , 2015, Applied & translational genomics.

[49]  M. Farrer,et al.  Disease penetrance of late-onset parkinsonism: a meta-analysis. , 2014, JAMA neurology.

[50]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[51]  W. Newman,et al.  Delivery of a Clinical Genomics Service , 2014, Genes.

[52]  A. Kerasidou SHARING THE KNOWLEDGE: SHARING AGGREGATE GENOMIC FINDINGS WITH RESEARCH PARTICIPANTS IN DEVELOPING COUNTRIES , 2014, Developing world bioethics.

[53]  N. Hallowell,et al.  Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues , 2014, Journal of Medical Ethics.

[54]  Jean-Baptiste Cazier,et al.  Choice of transcripts and software has a large effect on variant annotation , 2014, Genome Medicine.

[55]  Eric Vilain,et al.  Assessing the necessity of confirmatory testing for exome sequencing results in a clinical molecular diagnostic laboratory , 2014, Genetics in Medicine.

[56]  W. Kibbe,et al.  Review of Current Methods, Applications, and Data Management for the Bioinformatics Analysis of Whole Exome Sequencing , 2014, Cancer informatics.

[57]  Christian Gilissen,et al.  A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases , 2013, Human mutation.

[58]  K. Ormond From genetic counseling to “genomic counseling” , 2013, Molecular genetics & genomic medicine.

[59]  Susan M Wolf,et al.  Return of individual research results and incidental findings: facing the challenges of translational science. , 2013, Annual review of genomics and human genetics.

[60]  Lin Huang,et al.  Short read alignment with populations of genomes , 2013, Bioinform..

[61]  R. Green,et al.  Attitudes about regulation among direct-to-consumer genetic testing customers. , 2013, Genetic testing and molecular biomarkers.

[62]  Darragh G. McArt,et al.  Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis , 2013, PloS one.

[63]  S. Wyatt,et al.  Counseling Customers: Emerging Roles for Genetic Counselors in the Direct-to-Consumer Genetic Testing Market , 2013, Journal of Genetic Counseling.

[64]  J. Lawn,et al.  Health in South Africa: changes and challenges since 2009 , 2012, The Lancet.

[65]  Kris Dierickx,et al.  To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts , 2012, European Journal of Human Genetics.

[66]  Adam Kiezun,et al.  Exome sequencing and the genetic basis of complex traits , 2012, Nature Genetics.

[67]  Christopher A Cassa,et al.  Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility. , 2012, Genome research.

[68]  J. Herring,et al.  “Please Don’t Tell Me” , 2011, Cambridge Quarterly of Healthcare Ethics.

[69]  Omar E. Cornejo,et al.  Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence , 2011, PLoS genetics.

[70]  Muin J Khoury,et al.  Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.

[71]  Edwin Cuppen,et al.  Disclosure of individual genetic data to research participants: the debate reconsidered. , 2011, Trends in genetics : TIG.

[72]  Joanna Smith,et al.  Qualitative data analysis: the framework approach. , 2011, Nurse researcher.

[73]  George Church,et al.  Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants: Updated Guidelines from a National Heart, Lung, and Blood Institute Working Group , 2010, Circulation. Cardiovascular genetics.

[74]  Frances P Lawrenz,et al.  Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations , 2008, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[75]  A. McGuire,et al.  Research ethics and the challenge of whole-genome sequencing , 2008, Nature Reviews Genetics.

[76]  P. Sainsbury,et al.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[77]  J. Weil Genetic counselling in the era of genomic medicine , 2002, EMBO reports.

[78]  A. Clark To tell or not to tell , 2001, BMJ : British Medical Journal.

[79]  Z. M. Manyisa,et al.  Factors affecting working conditions in public hospitals: A literature review , 2017 .

[80]  E. Ashkinadze,et al.  125: Whole exome sequencing (WES) in prenatal diagnosis for carefully selected cases , 2017 .

[81]  E. Murphy,et al.  A response to 'Quality in qualitative evaluation: a framework for assessing research evidence' , 2004 .